Literature DB >> 468987

Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.

J C Gallagher, B L Riggs, J Eisman, A Hamstra, S B Arnaud, H F DeLuca.   

Abstract

Intestinal calcium absorption assessed by a double-isotope method, decreased significantly with aging in 94 normal subjects (r = -0.22, P < 0.025). In 52 untreated patients with postmenopausal osteoporosis, calcium absorption was significantly lower than normal when either age or habitual calcium intake was used as a covariable (P < 0.001). Serum 25-hydroxyvitamin D (25-OH-D) and 1,25-dihydroxyvitamin D (1,25(OH)(2)D) were measured in 44 normal subjects and 27 osteoporotic patients. For all normals, calcium absorption and serum 1,25(OH)(2)D were positively correlated (r = 0.50, P < 0.001). In nonelderly normal subjects (ages 30-65 yr), dietary calcium intake correlated inversely with both calcium absorption (r = -0.39, P < 0.01) and with serum 1,25(OH)(2)D (r = -0.50, P < 0.01). Both osteoporotic patients and elderly normal subjects (ages 65-90 yr) differed from nonelderly normals in that these correlations were not present. In addition although serum 25-OH-D was normal, serum 1,25(OH)(2)D was significantly decreased in both osteoporotic patients and elderly normals (P < 0.001). In osteoporotic patients, calcium absorption increased significantly (P < 0.001) after 7 d administration of a small dose (0.4 mug/d) of synthetic 1,25(OH)(2)D(3). In osteoporotics mean serum immunoreactive parathyroid hormone was either normal (COOH-terminal assay) or low (NH(2)-terminal assay) relative to age-matched controls, and mean serum phosphate was increased. The data suggest that inadequate metabolism of 25-OH-D to 1,25(OH)(2)D contributes significantly to decreased calcium absorption and adaptation in both osteoporotics and elderly normal subjects. In patients with osteoporosis this abnormality could result from a decrease in factors that normally stimulate 1,25(OH)(2)D production, such as the decreased parathyroid hormone secretion and increased serum phosphate demonstrated in this group. In elderly subjects a primary abnormality in metabolism of 25-OH-D to 1,25(OH)(2)D, analagous to that seen in aging rats, cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 468987      PMCID: PMC372174          DOI: 10.1172/JCI109516

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Intestinal absorption of 45Ca in senile osteoporosis.

Authors:  A CANIGGIA; C GENNARI; V BIANCHI; R GUIDERI
Journal:  Acta Med Scand       Date:  1963-05

3.  SPINAL OSTEOPOROSIS AND THE MENOPAUSE.

Authors:  C JASANI; B E NORDIN; D A SMITH; I SWANSON
Journal:  Proc R Soc Med       Date:  1965-06

4.  ISOTOPIC TRACER STUDIES OF INTESTINAL CALCIUM ABSORPTION.

Authors:  V R KINNEY; W N TAUXE; W H DEARING
Journal:  J Lab Clin Med       Date:  1965-08

5.  Calcium requirement and adaptation in adult men.

Authors:  O J MALM
Journal:  Scand J Clin Lab Invest       Date:  1958       Impact factor: 1.713

6.  The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.

Authors:  R A Kaplan; M R Haussler; L J Deftos; H Bone; C Y Pak
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

7.  The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism.

Authors:  R W Gray; D R Wilz; A E Caldas; J Lemann
Journal:  J Clin Endocrinol Metab       Date:  1977-08       Impact factor: 5.958

Review 8.  Current concepts in nutrition. Nutrition and bone disease.

Authors:  J C Gallagher; B L Riggs
Journal:  N Engl J Med       Date:  1978-01-26       Impact factor: 91.245

9.  Menopausal changes in calcium balance performance.

Authors:  R P Heaney; R R Recker; P D Saville
Journal:  J Lab Clin Med       Date:  1978-12

10.  A syndrome of osteoporosis, increased serum immunoreactive parathyroid hormone, and inappropriately low serum 1,25-dihydroxyvitamin D.

Authors:  B L Riggs; J C Gallagher; H F DeLuca; A J Edis; P W Lambert; C D Arnaud
Journal:  Mayo Clin Proc       Date:  1978-11       Impact factor: 7.616

View more
  133 in total

1.  Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey.

Authors:  J M Paik; W R Farwell; E N Taylor
Journal:  Osteoporos Int       Date:  2011-09-20       Impact factor: 4.507

2.  Prevention of post-menopausal bone loss with 1 alpha-hydroxy vitamin D3. A three-year prospective study.

Authors:  J M Pouilles; F Tremollieres; C Ribot
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

3.  Indications on the use of vitamin D and vitamin D metabolites in clinical phenotypes.

Authors:  M L Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2010-09

4.  Association between prolonged breastfeeding and bone mineral density and osteoporosis in postmenopausal women: KNHANES 2010-2011.

Authors:  I R Hwang; Y K Choi; W K Lee; J G Kim; I K Lee; S W Kim; K G Park
Journal:  Osteoporos Int       Date:  2015-09-15       Impact factor: 4.507

5.  Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study.

Authors:  Masayuki Iki; Takashi Akiba; Toshio Matsumoto; Harumi Nishino; Sadanobu Kagamimori; Yoshiko Kagawa; Hideo Yoneshima
Journal:  Osteoporos Int       Date:  2004-07-31       Impact factor: 4.507

6.  Radiocalcium absorption is reduced in postmenopausal women with vertebral and most types of peripheral fractures.

Authors:  B E Christopher Nordin; Peter D O'Loughlin; Allan G Need; Michael Horowitz; Howard A Morris
Journal:  Osteoporos Int       Date:  2003-11-04       Impact factor: 4.507

Review 7.  Risk factors for osteoporosis and associated fractures.

Authors:  J L Kelsey
Journal:  Public Health Rep       Date:  1989 Sep-Oct       Impact factor: 2.792

8.  1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis.

Authors:  J C Gallagher; C M Jerpbak; W S Jee; K A Johnson; H F DeLuca; B L Riggs
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

9.  Gastrointestinal calcium absorption and dietary calcium load: relationships with bone remodelling in vertebral osteoporosis.

Authors:  M Tellez; M E Arlot; E B Mawer; A Diaz; R Hesp; P Hulme; C Edouard; J R Green; P J Meunier; J Reeve
Journal:  Osteoporos Int       Date:  1995-01       Impact factor: 4.507

10.  Acute suppression of bone turnover with calcium infusion in persons with spinal cord injury.

Authors:  William A Bauman; Run-Lin Zhang; Nancy Morrison; Ann M Spungen
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.